A review of repetitive transcranial magnetic stimulation for adolescents with treatment-resistant depression

Leela R. Magavi, Irving M. Reti, Roma A. Vasa

Research output: Contribution to journalReview article

Abstract

This review examines the efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) as a treatment for treatment-resistant depression in adolescents. A systematic review of six databases was conducted. Ten multi-subject trials, all uncontrolled, and five case reports met inclusion criteria. Twelve studies focused on treatment efficacy, whereas three studies focused exclusively on adverse events. All efficacy studies focused on adolescents only; 10 of these studies indicated that rTMS may demonstrate some benefit. Improvement within 2–8 weeks was reported in most studies, with a few studies indicating potential long-term benefits. A variety of adverse events occurred including scalp pain, which was the most common, as well as seizures. Controlled studies of rTMS are warranted to further examine whether this treatment is a potential option for adolescents with treatment-resistant depression.

Original languageEnglish (US)
Pages (from-to)79-88
Number of pages10
JournalInternational Review of Psychiatry
Volume29
Issue number2
DOIs
StatePublished - Mar 4 2017

Fingerprint

Treatment-Resistant Depressive Disorder
Transcranial Magnetic Stimulation
Scalp
Seizures
Safety
Pain

Keywords

  • Depression
  • paediatric
  • repetitive transcranial magnetic stimulation

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

A review of repetitive transcranial magnetic stimulation for adolescents with treatment-resistant depression. / Magavi, Leela R.; Reti, Irving M.; Vasa, Roma A.

In: International Review of Psychiatry, Vol. 29, No. 2, 04.03.2017, p. 79-88.

Research output: Contribution to journalReview article

Magavi, Leela R.; Reti, Irving M.; Vasa, Roma A. / A review of repetitive transcranial magnetic stimulation for adolescents with treatment-resistant depression.

In: International Review of Psychiatry, Vol. 29, No. 2, 04.03.2017, p. 79-88.

Research output: Contribution to journalReview article

@article{5f8ba90299974167a12c15fd4576473c,
title = "A review of repetitive transcranial magnetic stimulation for adolescents with treatment-resistant depression",
abstract = "This review examines the efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) as a treatment for treatment-resistant depression in adolescents. A systematic review of six databases was conducted. Ten multi-subject trials, all uncontrolled, and five case reports met inclusion criteria. Twelve studies focused on treatment efficacy, whereas three studies focused exclusively on adverse events. All efficacy studies focused on adolescents only; 10 of these studies indicated that rTMS may demonstrate some benefit. Improvement within 2–8 weeks was reported in most studies, with a few studies indicating potential long-term benefits. A variety of adverse events occurred including scalp pain, which was the most common, as well as seizures. Controlled studies of rTMS are warranted to further examine whether this treatment is a potential option for adolescents with treatment-resistant depression.",
keywords = "Depression, paediatric, repetitive transcranial magnetic stimulation",
author = "Magavi, {Leela R.} and Reti, {Irving M.} and Vasa, {Roma A.}",
year = "2017",
month = "3",
doi = "10.1080/09540261.2017.1300574",
volume = "29",
pages = "79--88",
journal = "International Review of Psychiatry",
issn = "0954-0261",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - A review of repetitive transcranial magnetic stimulation for adolescents with treatment-resistant depression

AU - Magavi,Leela R.

AU - Reti,Irving M.

AU - Vasa,Roma A.

PY - 2017/3/4

Y1 - 2017/3/4

N2 - This review examines the efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) as a treatment for treatment-resistant depression in adolescents. A systematic review of six databases was conducted. Ten multi-subject trials, all uncontrolled, and five case reports met inclusion criteria. Twelve studies focused on treatment efficacy, whereas three studies focused exclusively on adverse events. All efficacy studies focused on adolescents only; 10 of these studies indicated that rTMS may demonstrate some benefit. Improvement within 2–8 weeks was reported in most studies, with a few studies indicating potential long-term benefits. A variety of adverse events occurred including scalp pain, which was the most common, as well as seizures. Controlled studies of rTMS are warranted to further examine whether this treatment is a potential option for adolescents with treatment-resistant depression.

AB - This review examines the efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) as a treatment for treatment-resistant depression in adolescents. A systematic review of six databases was conducted. Ten multi-subject trials, all uncontrolled, and five case reports met inclusion criteria. Twelve studies focused on treatment efficacy, whereas three studies focused exclusively on adverse events. All efficacy studies focused on adolescents only; 10 of these studies indicated that rTMS may demonstrate some benefit. Improvement within 2–8 weeks was reported in most studies, with a few studies indicating potential long-term benefits. A variety of adverse events occurred including scalp pain, which was the most common, as well as seizures. Controlled studies of rTMS are warranted to further examine whether this treatment is a potential option for adolescents with treatment-resistant depression.

KW - Depression

KW - paediatric

KW - repetitive transcranial magnetic stimulation

UR - http://www.scopus.com/inward/record.url?scp=85019612630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019612630&partnerID=8YFLogxK

U2 - 10.1080/09540261.2017.1300574

DO - 10.1080/09540261.2017.1300574

M3 - Review article

VL - 29

SP - 79

EP - 88

JO - International Review of Psychiatry

T2 - International Review of Psychiatry

JF - International Review of Psychiatry

SN - 0954-0261

IS - 2

ER -